Apeloa Pharmaceutical Co.,Ltd
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 000739.SZ | INDSWFTLAB.BO | SOLARA.NS | WINDLAS.NS | 034940.KQ | 000623.SZ | |
|---|---|---|---|---|---|---|
| Market cap | 25.56B | 31.50B | 31.04B | 19.01B | 9.98B | 20.71B |
| P/E (TTM) | 31.5 | 37.0 | 83.4 | 29.5 | — | 6.8 |
| Forward P/E | 21.4 | — | 20.5 | — | — | 7.9 |
| Price/book | 3.9 | 2.1 | 2.2 | 3.3 | — | 0.6 |
| Dividend yield | 1.75% | — | — | 0.72% | — | 2.88% |
| 1-year change | +43.01% | +268.15% | +14.61% | −5.35% | −69.57% | −16.84% |
| Today | +2.22% | −4.09% | −0.25% | +5.47% | 0.00% | −0.35% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All 000739.SZ news ›Frost & Sullivan Honors Apeloa Pharmaceutical Co., Ltd. with the "2026 Global CDMO Company of the Year Award"
Shanghai China October 10 2026 On August 4 2026 the 20th Frost Sullivan Global Growth Innovation and Leadership Summit and the 5th New Investment Event commenced at the Jing An Shangri La in Shanghai The gala dinner celebrating Frost…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- digitaljournal.com1
- newsfilecorp.com1
- openpr.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.